HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Junji Yodoi Selected Research

Insulin (Novolin)

10/2011Thioredoxin-interacting protein suppresses bladder carcinogenesis.
12/2010Thioredoxin binding protein-2 mediates metabolic adaptation in response to lipopolysaccharide in vivo.
2/2010Thioredoxin binding protein-2 inhibits excessive fetal hypoglycemia during maternal starvation by suppressing insulin secretion in mice.
1/2008Transgenic expression of antioxidant protein thioredoxin in pancreatic beta cells prevents progression of type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Junji Yodoi Research Topics

Disease

25Inflammation (Inflammations)
05/2022 - 08/2002
16Neoplasms (Cancer)
01/2014 - 03/2002
7Infections
10/2020 - 06/2002
7Myocarditis (Carditis)
06/2007 - 08/2002
6Chronic Obstructive Pulmonary Disease (COPD)
09/2021 - 10/2007
6Carcinogenesis
09/2021 - 01/2002
6Asthma (Bronchial Asthma)
10/2020 - 04/2003
6Ischemia
10/2020 - 01/2002
6Hypoxia (Hypoxemia)
08/2020 - 01/2002
6Hepatitis
10/2009 - 05/2003
5Fibrosis (Cirrhosis)
01/2013 - 11/2003
5Pneumonia (Pneumonitis)
01/2013 - 06/2002
5Lung Injury
10/2007 - 11/2003
5T-Cell Leukemia (Leukemia, T Cell)
10/2007 - 02/2002
4Body Weight (Weight, Body)
08/2021 - 01/2008
4Reperfusion Injury
12/2014 - 10/2003
4Ulcer
01/2014 - 03/2002
4Hemorrhage
09/2012 - 01/2006
4Type 2 Diabetes Mellitus (MODY)
01/2012 - 01/2008
4Hypoglycemia (Reactive Hypoglycemia)
12/2010 - 03/2009
4Chest Pain (Chest Pains)
03/2005 - 09/2003
3Obstructive Sleep Apnea
05/2022 - 04/2008
3Lung Diseases (Lung Disease)
09/2021 - 10/2007
3Myocardial Infarction
08/2020 - 09/2003
3Acute Lung Injury
04/2016 - 10/2007
3Non-alcoholic Fatty Liver Disease
01/2013 - 01/2003
3Emphysema
01/2013 - 03/2007
3Necrosis
09/2012 - 06/2002
3Cardiovascular Diseases (Cardiovascular Disease)
11/2009 - 12/2003
3Reye Syndrome (Reye's Syndrome)
10/2009 - 01/2006
3Myocardial Ischemia (Ischemic Heart Diseases)
06/2007 - 08/2004
3Heart Diseases (Heart Disease)
06/2007 - 08/2002
3Heart Failure
06/2007 - 08/2002
3Muscle Spasticity (Spastic)
02/2004 - 09/2003
2Kidney Diseases (Kidney Disease)
01/2022 - 12/2014
2Hyperglycemia
08/2021 - 01/2008
2Interstitial Lung Diseases (Interstitial Lung Disease)
10/2020 - 01/2007
2Virus Diseases (Viral Diseases)
10/2020 - 04/2016
2Viral Pneumonia
10/2020 - 04/2016
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
10/2020 - 06/2007
2Chronic Renal Insufficiency
08/2020 - 12/2014
2Stomach Ulcer (Gastric Ulcer)
01/2014 - 08/2007
2Edema (Dropsy)
07/2013 - 09/2012
2Human Influenza (Influenza)
01/2013 - 01/2005
2Contact Dermatitis (Eczema, Contact)
01/2013 - 06/2009
2Diabetes Mellitus
01/2012 - 11/2005
2Insulin Resistance
01/2012 - 11/2010
2Glucose Intolerance
11/2010 - 11/2005
2Fatty Liver
10/2009 - 01/2003
2Respiratory Hypersensitivity
08/2007 - 09/2005

Drug/Important Bio-Agent (IBA)

95ThioredoxinsIBA
05/2022 - 01/2002
38Proteins (Proteins, Gene)FDA Link
09/2017 - 08/2002
16CytokinesIBA
05/2022 - 11/2003
14AntioxidantsIBA
09/2021 - 06/2002
11Reactive Oxygen Species (Oxygen Radicals)IBA
09/2021 - 04/2003
11tributyl phosphate (TBP)IBA
01/2012 - 03/2002
10human TXNIP proteinIBA
01/2012 - 09/2004
6Pharmaceutical PreparationsIBA
10/2020 - 03/2002
6Biomarkers (Surrogate Marker)IBA
08/2020 - 02/2002
6EnzymesIBA
08/2020 - 08/2002
6ChemokinesIBA
04/2016 - 09/2004
5Messenger RNA (mRNA)IBA
01/2017 - 09/2005
5Carrier Proteins (Binding Protein)IBA
01/2017 - 02/2004
5Glucose (Dextrose)FDA LinkGeneric
01/2012 - 11/2005
4Acetylcysteine (Siran)FDA LinkGeneric
09/2021 - 02/2002
4Insulin (Novolin)FDA Link
10/2011 - 01/2008
4LipopolysaccharidesIBA
12/2010 - 05/2003
4Thioacetamide (Thioacetamid)IBA
10/2008 - 05/2003
4Bleomycin (Blenoxane)FDA LinkGeneric
10/2007 - 11/2003
3Peptide Hydrolases (Proteases)FDA Link
09/2021 - 08/2002
3Indomethacin (Indometacin)FDA LinkGeneric
04/2016 - 08/2007
3SmokeIBA
01/2013 - 10/2007
3InterleukinsIBA
10/2010 - 11/2003
3Glutathione (Reduced Glutathione)IBA
02/2008 - 06/2002
3Transaminases (Aminotransferases)IBA
03/2006 - 06/2003
3Vitamin EFDA LinkGeneric
05/2004 - 07/2003
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
06/2003 - 08/2002
3temocapril hydrochloride (temocapril)IBA
06/2003 - 08/2002
2Blood Glucose (Blood Sugar)IBA
08/2021 - 02/2010
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2020 - 05/2005
2Anti-Allergic Agents (Antiallergic Agents)IBA
10/2020 - 04/2016
2Antineoplastic Agents (Antineoplastics)IBA
10/2020 - 04/2016
2DNA (Deoxyribonucleic Acid)IBA
01/2014 - 02/2008
2Ethanol (Ethyl Alcohol)IBA
01/2014 - 07/2007
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
10/2012 - 08/2004
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2012 - 05/2008
2Transcription Factors (Transcription Factor)IBA
01/2012 - 09/2009
2LipidsIBA
12/2010 - 09/2007
2Fatty Acids (Saturated Fatty Acids)IBA
12/2010 - 01/2006
2Interleukin-13IBA
03/2010 - 08/2007
2AntigensIBA
06/2009 - 08/2007
2Streptozocin (Streptozotocin)FDA Link
05/2009 - 06/2007
2IronIBA
12/2008 - 06/2003
2OvalbuminIBA
05/2008 - 08/2007
2Glutathione PeroxidaseIBA
02/2008 - 10/2007
2CatalaseIBA
10/2007 - 03/2006
2Cysteine (L-Cysteine)FDA Link
09/2007 - 06/2002

Therapy/Procedure

15Therapeutics
05/2022 - 06/2002
3Drug Therapy (Chemotherapy)
10/2020 - 05/2006
2Oral Administration
01/2014 - 01/2004